Detalhe da pesquisa
1.
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Cell
; 187(3): 596-608.e17, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194966
2.
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
Cell
; 185(3): 447-456.e11, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026151
3.
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
Cell
; 184(9): 2384-2393.e12, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794143
4.
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.
J Med Virol
; 95(1): e28124, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056630
5.
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
Int J Mol Sci
; 23(22)2022 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430535
6.
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.
Clin Infect Dis
; 73(11): 2000-2008, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134134
7.
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
Lancet
; 398(10305): 1041-1042, 2021 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416198
8.
Cytoskeletal ß-tubulin and cysteine cathepsin L deregulation by SARS-CoV-2 spike protein interaction with the neuronal model cell line SH-SY5Y.
Biochimie
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38432290
9.
Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein.
JACS Au
; 3(6): 1755-1766, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37388683
10.
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection.
Viruses
; 15(2)2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851486
11.
Omicron subvariant BA.5 efficiently infects lung cells.
Nat Commun
; 14(1): 3500, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311762
12.
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2.
Cell Mol Immunol
; 19(3): 449-452, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983951
13.
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy.
mBio
; 13(3): e0036422, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467423
14.
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination.
Cell Rep
; 39(5): 110754, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477025
15.
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies.
Cell Host Microbe
; 30(8): 1103-1111.e6, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588741
16.
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1.
Viruses
; 14(11)2022 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366573
17.
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization.
Cell Rep
; 35(3): 109017, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857422
18.
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination.
Cell Rep
; 37(2): 109825, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614392
19.
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.
Cell Rep
; 36(3): 109415, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270919
20.
Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany.
Lancet Infect Dis
; 24(3): e145-e146, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38211602